Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/13/2008WO2008135153A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135152A1 Novel amorphous forms of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135141A1 2 -heteroaryl- pyrrolo [3, 4-c] pyrrole derivatives and their use as scd inhibitors
11/13/2008WO2008135085A1 Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds
11/13/2008WO2008135041A1 Adamantyloxyamine derivatives and related compounds for use as nmda and/or dpp-4 modulators for the therapy of cns diseases and diabetes
11/13/2008WO2008134882A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008WO2008134844A1 Branched-chain amino acid composition for improving skeletal muscle protein metabolism
11/13/2008WO2008121941B1 Prodrugs of triciribine and triciribine phosphate
11/13/2008WO2008118718A3 2-aminopyridine analogs as glucokinase activators
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008115478A3 Method of cancer detection and treatment
11/13/2008WO2008115369A3 Inhibitors of focal adhesion kinase
11/13/2008WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
11/13/2008WO2008115069A3 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
11/13/2008WO2008114275A3 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof
11/13/2008WO2008113901A3 Composition with controlled release of levetiracetam and method for preparing same
11/13/2008WO2008113760A3 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
11/13/2008WO2008113469A3 Substituted imidazopyrimidines and triazolopyrimidines
11/13/2008WO2008113360A3 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
11/13/2008WO2008113359A3 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
11/13/2008WO2008112939A3 Composition and method for making oligo-benzamide compounds
11/13/2008WO2008112641A3 Methods and compositions for treating thalamocortical dysrhythmia
11/13/2008WO2008112319A3 Methods of treating parkinson's disease using halogenated volatile compounds
11/13/2008WO2008111020A3 Macrolide derivatives as antibacterial agents
11/13/2008WO2008110697A3 Use of a compound antagonist to the nk2 receptors of a neurokinine for the preparation of drugs useful for preventing and treating sexual dysfunction
11/13/2008WO2008109837A3 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
11/13/2008WO2008109493A3 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
11/13/2008WO2008109474B1 Nucleic acid compounds for inhibiting fgf2 gene expression and uses thereof
11/13/2008WO2008109397A3 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
11/13/2008WO2008109365B1 Nucleic acid compounds for inhibiting raf1 gene expression and uses thereof
11/13/2008WO2008109362B1 Nucleic acid compounds for inhibiting vegf gene expression and uses thereof
11/13/2008WO2008105808A3 FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
11/13/2008WO2008103461A3 Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
11/13/2008WO2008103319A3 Compounds and methods for use in detecting gabapentin
11/13/2008WO2008102145A3 Process for the preparation of esomeprazole magnesium dihydrate
11/13/2008WO2008100628A3 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases
11/13/2008WO2008100620A3 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
11/13/2008WO2008100547A3 Compositions comprising lamiridosin, iridoids or derivatives thereof for treatment of hepatitis c or hepatitis b
11/13/2008WO2008099186A8 Heterocyclic derivatives as m3 muscarinic receptors
11/13/2008WO2008099072A3 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
11/13/2008WO2008097640A8 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
11/13/2008WO2008097468A3 Selective endothelin type-a antagonists
11/13/2008WO2008094640A3 Compounds having anti-adhesive effects on cancer cells
11/13/2008WO2008094602A3 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases
11/13/2008WO2008092103A9 Combination cancer treatments comprising elsamitrucin and other agents
11/13/2008WO2008090416A3 Tumor suppressor functions of the rb-skp2 pathway are disabled in high risk but functional in low-risk neuroblastomas
11/13/2008WO2008089403A3 Oligosaccharides comprising an aminooxy group and conjugates thereof
11/13/2008WO2008087354A3 Cream-gel comprising at least one retinoid and benzoyl peroxide
11/13/2008WO2008086079A3 Compositions comprising rnai and a neurotrophic factor and uses thereof
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008083326A3 Targeting of ews-fli1 as anti-tumor therapy
11/13/2008WO2008083130A3 Amorphous and crystalline form a of carvedilol phosphate
11/13/2008WO2008082562A3 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
11/13/2008WO2008082520A3 Inhibition of ppar gamma expression by specific osteogenic oxysterols
11/13/2008WO2008080162A3 Anti-cholesterolemic compounds and methods of use
11/13/2008WO2008079030A8 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
11/13/2008WO2008078100A3 Tricyclic amine derivatives as protein tyrosine kinase inhibitors
11/13/2008WO2008076805B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
11/13/2008WO2008076270A3 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
11/13/2008WO2008073959A3 Synthetic agonists of tlr9
11/13/2008WO2008068638A3 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
11/13/2008WO2008066887A3 Small molecule inhibitors of bcl6
11/13/2008WO2008066620A3 Dibenzothiazepine derivatives
11/13/2008WO2008065500A3 Heteroaryl amides as type i glycine transport inhibitors
11/13/2008WO2008064265A3 Compounds modulating c-fms and/or c-kit activity and uses therefor
11/13/2008WO2008063847A3 Method for treating autism
11/13/2008WO2008063778A3 Synergistic combinations of antineoplastic thiol-binding mitochondrial oxidants and antineoplastic corticosteriods for the treatment of cancer
11/13/2008WO2008063563A9 Methods of treating keratin hyperproliferation disorders using mtor inhibitors
11/13/2008WO2008060837A3 Methods and compositions for the treatment of cancer
11/13/2008WO2008060397A3 Method of treating thermoregulatory disfunction
11/13/2008WO2008058291A3 Modular aptamer-regulated ribozymes
11/13/2008WO2008052072A3 Compounds for the treatment of pain and screening methods therefor
11/13/2008WO2008045860A3 Methods of inactivating viruses
11/13/2008WO2008045627A3 Protein kinase inhibitors and methods for using thereof
11/13/2008WO2008045170A3 Statin and omega-3 fatty acids for reduction of apo-b levels
11/13/2008WO2008043974A3 Two-compartment skincare products comprising ivermectin, and uses thereof
11/13/2008WO2008039520A3 Fused ring compounds for inflammation and immune-related uses
11/13/2008WO2008036846A3 Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
11/13/2008WO2008036792A3 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors
11/13/2008WO2008034908A3 Use of vitamin d compounds for the prevention of adhesions
11/13/2008WO2008033545A3 Triphenylphosphine oxide derivatives and uses thereof
11/13/2008WO2008031028A3 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
11/13/2008WO2008027580A3 PARTICULATE β-GLUCAN COMPOSITIONS FOR REGULATING DENDRITIC CELLS
11/13/2008WO2008027356A3 Compositions containing cdp-choline, and methods of use thereof
11/13/2008WO2008024715A3 Tonsillitis treatment
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008WO2008016659A3 Agents for treating neurodegenerative diseases
11/13/2008WO2008013631A3 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay
11/13/2008WO2008011538A3 Methods of using flavonoids to enhance memory
11/13/2008WO2008011484A3 Nicotinic desensitizers and methods of selecting, testing, and using them
11/13/2008WO2008011045A3 3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
11/13/2008WO2008008720A3 Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
11/13/2008WO2008008719A3 Compositions and methods for inhibiting expression of the myc gene
11/13/2008WO2008006036A3 Conditioned cell immunization
11/13/2008WO2008005908A3 Pyridoimidazole derivatives
11/13/2008WO2007149543A3 Scar treatment using protein phosphatase inhibitors
11/13/2008WO2007147839A9 Glycine transporter inhibiting compounds and uses in medicine
11/13/2008WO2007147109A3 Novel compounds
11/13/2008WO2007147103A3 Novel compounds
11/13/2008WO2007146957A3 Ror1 as a therapeutic target for lung cancer
1 ... 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 ... 7860